Latest News and Press Releases

Oslo (Norway), 22 July 2019 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed...

Oslo, Norway, July 1, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the...

Oslo, 21 June 2019     In accordance with the authorisation granted by the Annual General Meeting 29 May 2019, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 320,000 share...

Oslo, 29 May 2019. The Annual General Meeting in PCI Biotech Holding ASA took place today, 29 May 2019. All proposals were resolved by the Annual General Meeting as presented in the notice convening...

Oslo, 28 May 2019. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall...

Oslo (Norway), 23 May 2019 – PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced first...

Oslo, Norway 8 May 2019 - The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday May 29, 10am CEST...

Oslo (Norway), 8 May 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its first quarter 2019 result. Please find enclosed the report and presentation. First...

Oslo (Norway), 2 May 2019 – PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced that the...

Oslo, Norway, 30 April 2019 - PCI Biotech invites to a presentation of the company's first quarter 2019 result on Wednesday 8 May 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 8...